Cytokinetics Inc (CYTK) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $62.63
• Market Cap: $7.69B
• EPS: $-6.30
• 52-Week High: $70.98
• 52-Week Low: $29.31

Market Sentiment

Cytokinetics Inc currently has a Bullish sentiment score of 0.22.

About Cytokinetics Inc

Cytokinetics, Incorporated is a clinical-stage biopharmaceutical company based in South San Francisco, California, dedicated to discovering and developing innovative muscle activators and inhibitors for the treatment of debilitating diseases, including heart failure and various muscle disorders. With a strong and expanding pipeline, the company is advancing therapies that leverage its unique expertise in muscle biology, positioning Cytokinetics as a leader in therapeutic advancements in this ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Cytokinetics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CYTK pay dividends?

Cytokinetics Inc (CYTK) does not currently pay a regular dividend.

What is CYTK's market cap?

Cytokinetics Inc (CYTK) has a market capitalization of $7.69B with a current stock price of $62.63.